Lyra Therapeutics (NASDAQ: LYRA) ‘s shares surged 550% in pre-market trading on Monday following a breakthrough in its drug trials.The stock, which closed at $4.93 on Friday, jumped to over$32 in early trading despite being down more than 50% year-to-date.LYRA one-day stock price chart. Source: Google FinanceThe rally comes after the biotech company announced that its drug candidate, LYR-210, delivered statistically significant results in treating chronic rhinosinusitis (CRS) in adults.Specifically, the EN ...